Fundz

Fundz Deep Dive

Everything you need to win John B. Moriarty, Jr., J.D. — in one platform.

Who to reach, what to say, and why now on John B. Moriarty, Jr., J.D. — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on John B. Moriarty, Jr., J.D. — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

Avidity Biosciences Appoints John B. Moriarty, Jr., J.D., As Chief Legal Officer and Corporate Secretary

PRIVATEAug 05, 2024•almost 2 years ago

Position

Corporate Secretary

Company

Avidity Bioscience

John B. Moriarty, Jr., J.D.
Biotechnology

Description

Avidity Biosciences, Inc. announced the appointment of John B. Moriarty, Jr., J.D., as Chief Legal Officer and Corporate Secretary, effective immediately

Company Information

Company

Avidity Bioscience

Location

10578 Science Center Dr

About

Avidity Bioscience is a biotechnology company focused on developing a new class of therapies for the treatment of rare diseases. The company's innovative technology platform aims to deliver RNA-based medicines using a new approach. Avidity's mission is to improve patient outcomes by providing targeted therapies.

Predictive Intelligence
Strategic

ML-powered predictions for Avidity Bioscience's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.